TLR4 and diabetic kidney disease: It was reported that 1,25(OH)2D3 (44) inhibits inflammatory cell infiltration and tubulointerstitial fibrosis by downregulating the TLR4-MyD88-NF-κB pathway and thus exhibits protective effects on DKD.